Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-12
2006-09-12
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S269000, C544S298000, C544S327000, C544S328000
Reexamination Certificate
active
07105523
ABSTRACT:
This invention relates to compounds of the formulawherein R1is H or a di-C1-6-alkylaminocarbonyl raical, and R2is a radical of the formula —O—C(X)—NR3R4wherein X is O or S. A process for preparing such compounds, pharmaceutical compositions containing them, and methods for using them in treatment of hypertension are also disclosed and claimed.
REFERENCES:
patent: 6166027 (2000-12-01), Straub et al.
patent: 6180656 (2001-01-01), Furstner et al.
patent: 6387940 (2002-05-01), Straub et al.
patent: 6410740 (2002-06-01), Straub et al.
patent: 6414009 (2002-07-01), Straub et al.
patent: 6451805 (2002-09-01), Straub et al.
patent: 6462068 (2002-10-01), Straub et al.
patent: 9816223 (1998-04-01), None
patent: 9816507 (1998-04-01), None
patent: 9823619 (1998-05-01), None
patent: 0006567 (2000-02-01), None
patent: 0006568 (2000-02-01), None
patent: 0006569 (2000-02-01), None
patent: 0021954 (2000-04-01), None
Damasio, Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.
Layzer, Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.
Wolin et al., Review: Oxidant-NO Signalling Mechanism in Vascular Tissue, Biochemistry (Moscow), vol. 63, No. 7, 810/958, 1998.
Prandoni, The treatment of venous thromboembolic disorders: new challenges and opportunities, Haematologica/Journal of Hematology, vol. 88(05), pp. 610-613, 2003.
Fisker et al., PubMed Abstract (J Endocrin Invest. 22(5 Suppl):89-93), 1999.
Ko et al., “YC-1, a Novel Activator of Platelet Guanylate Cyclase”, Blood 84 4226-4233 (1994).
Mulsch, et al., “Effect of YC-1, and NO-independent, Superoxide-Sensitive Stimulator of Soluble Guanylyl Cyclase, on Smooth Muscle Responsiveness to Nitrovasodilators”, Brit. J. of Pharmacol. 120 681-689 (1997).
Glass et al., “Stimulation of Human Platelet Guanylate Cyclase by Fatty Acids”, J. of Biol. Chem. 252 1279-1285 (1977).
Pettibone et al., “A Structurally Novel Stimulator of Guanylate Cyclase with Long-lasting Hypotensive Activity in the Dog”. Euro. J. of Pharmacol. 116, 307-312 (1985).
Yu et al., “Vasorelaxant Effect of Isoliquiritigenin, a Novel Soluble Guanylate Cyclase Activator , in Rat Aorta” Brit J. of Pharmacol. 114 1587-1594 (1995).
Alonso-Alija Cristina
Dembowsky Klaus
Feurer Achim
Flubacher Dietmar
Lang Dieter
Bayer Aktiengeselischaft
Rao Deepak
LandOfFree
Carbamate-substituted pyrazolopyridine-derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamate-substituted pyrazolopyridine-derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamate-substituted pyrazolopyridine-derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3530052